Hiyama Y, Hosoya T, Tarutani O, Ito K
Nihon Naibunpi Gakkai Zasshi. 1986 Jan 20;62(1):1-8. doi: 10.1507/endocrine1927.62.1_1.
Peroxidase activity in thyroid tissue from 25 patients with Graves' disease was measured by Mini assay method (J. Biochem. 98, 637-647, 1985) employing guaiacol or iodide as a second substrate. The mean values of protein-based specific activity were 0.496 guaiacol unit/mg protein and 0.187 iodide unit/mg protein, reaching 16 fold and 28 fold those of normal thyroids, respectively. The mean value of ratio of iodide unit to guaiacol unit in each thyroid, 0.68, was also much higher than that of normal human thyroid, 0.16. No significant difference in peroxidase activity was observed between patients treated with methylmercaptoimidazole and those with propylthiouracil, but the activities of those groups were significantly higher than those of patients treated with potassium iodide, suggesting that inorganic iodine therapy plays some role in suppressing the synthesis of thyroid peroxidase in vivo.
采用迷你分析法(《生物化学杂志》98卷,637 - 647页,1985年),以愈创木酚或碘化物作为第二底物,测定了25例格雷夫斯病患者甲状腺组织中的过氧化物酶活性。以蛋白质为基础的比活性平均值分别为0.496愈创木酚单位/毫克蛋白质和0.187碘化物单位/毫克蛋白质,分别达到正常甲状腺的16倍和28倍。每个甲状腺中碘化物单位与愈创木酚单位的比值平均值为0.68,也远高于正常人类甲状腺的0.16。接受甲巯咪唑治疗的患者和接受丙硫氧嘧啶治疗的患者之间,过氧化物酶活性未观察到显著差异,但这两组患者的活性显著高于接受碘化钾治疗的患者,这表明无机碘疗法在体内抑制甲状腺过氧化物酶的合成中发挥了一定作用。